Serum Basic Fibroblast Growth Factor in Pediatric Crohn's Disease (Implications for Wound Healing) (original) (raw)

REFERENCES

  1. Sartor RB: Current concepts in the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am 24:475–507, 1995
    Google Scholar
  2. Yang H, Rotter JI: Genetic aspects of idiopathic inflammatory bowel disease. In Inflammatory Bowel Disease, 4th ed. JB Kirsner, RG Shorter. (eds). Baltimore, Williams and Wilkins, 1995, pp 301–334
    Google Scholar
  3. Schreiber S, Raedler A, Stenson WF, McDermott RP: The role of the mucosal immune system in inflammatory bowel disease. Gastroenterol Clin North Am 21:451–502, 1992
    Google Scholar
  4. Wakefield AJ, Dhillon AP, Rowles PM, Sawyer AM, Pittilo RM, Lewis AM, Pounder RE: Pathogenesis of Crohn's disease: Multifocal gastrointestinal infarction. Lancet 2:1057–1062, 1989
    Google Scholar
  5. Schweigerer L, Fotsis T: Angiogenesis and angiogenesis inhibitors in pediatric diseases. Eur J Pediatr 151:472–476, 1992
    Google Scholar
  6. Rifkin DB, Moscatelli D: Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol 106:1–6, 1989
    Google Scholar
  7. Slavin A: Fibroblast growth factors: at the heart of angiogenesis. Cell Biol Int 19:431–444, 1995
    Google Scholar
  8. Friese RE, Maciag T: Molecular mechanisms of angiogenesis: Fibroblast growth factor signal transduction. FASEB J 9:919–925, 1995 (review)
    Google Scholar
  9. Folkman J: Clinical application of research on angiogenesis. N Engl J Med 333:1757–1763, 1995
    Google Scholar
  10. New BA, Yeoman LC: Identification of basic fibroblast growth factor and sensitivity and receptor and ligand expression in human colon tumor cell lines. J Cell Physiol 150:320–326, 1992
    Google Scholar
  11. Nice EC, Fabri L, Whitehead RH, James R, Simpson RJ, Burgess AW: The major colonic cell mitogen extractable from colonic mucosa is an N-terminally extended form of basic fibroblast growth factor. J Biol Chem 22:14425–14430, 1991
    Google Scholar
  12. Cordon-Cardo C, Vlodaavsky I, Haimovitz-Friedman A, Hicklin D, Fuks Z: Expression of basic fibroblast growth factor in human tissues. Lab Invest 63:832–840, 1990
    Google Scholar
  13. Schulze-Orloff K, Risau W, Vollmer E, Sorg C: In situ detection of basic fibroblast growth factor by highly specific antibodies. Am J Pathol 137:85–92, 1990
    Google Scholar
  14. Dignass AU, Tsukenawa S, Podolsky DK: Fibroblast growth factors modulate intestinal epithelial cell growth and migration. Gastroenterology 106:1254–1262, 1994
    Google Scholar
  15. Szabo S, Folkman J, Vattay P, Morales RE, Pinkus G, Kato K: Accelerated healing of duodenal ulcers by oral administration of a mutein of basic fibroblast growth factor in rats. Gastroenterology 106:1106–1111, 1994
    Google Scholar
  16. D'Amore PA, Brown RH, Ku PT, Hoffman EP, Watanabe H, Arahata K, Ishihara T, Folkman J: Elevated serum basic fibroblast growth factor in the serum of patients with Duchenne muscular dystrophy. Ann Neurol 35:362–365, 1994
    Google Scholar
  17. Hyams JS, Ferry GD, Mandel FS, Gryboski JD, Kibort PM, Kirschner BS, Griffiths AM, Katz AJ, Granel RJ, Boyle JT, Michener WM, Levy JS, Lesser ML: Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 12:439–447, 1991
    Google Scholar
  18. Hyams JS, Fitzgerald JE, Treem WR, Wyzga N, Kreutzer DL: Relationship of functional and antigenic interleukin-6 to disease activity in inflammatory bowel disease. Gastroenterology 104:1285–92, 1993
    Google Scholar
  19. Kozarek RA, Patterson DJ, Gelfand MD, Botoman VA, Ball TJ, Wilske KR: Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Intern Med 110:353–356, 1989
    Google Scholar
  20. Miller RG: Simultaneous Statistical Inference, 2nd ed. New York: Springer-Verlag, 1981, pp 67–73
    Google Scholar
  21. Hamilton LC: Regression with Graphics: A Second Course in Applied Statistics. Belmont, California; Duxbury Press, 1992, pp 163–174
    Google Scholar
  22. Bross DA, Leichtner AM, Zurakowski D, Law T, Bousvaros A: Elevation of serum interleukin-6 but not soluble interleukin-2 receptor in children with Crohn's disease. J Pediatr Gastroenterol Nutr 23:164–171, 1996
    Google Scholar
  23. Olwin BB, Arthur K, Hannon K, Hein P, McFall A, Riley B, Szebenyi G, Zhaohui Zhou, Zuber ME, Rapraeger AC, Fallon JF, Kudla AJ: Role of FGF's in skeletal muscle and limb development. Mol reprod dev 39:90–101, 1994
    Google Scholar
  24. Chua CC, Chua BH, Zhao ZY, Krebs C, Diglio C, Perrin E: Effect of growth factors on collagen metabolism in cultured human heart fibroblasts. Connect Tissue Res 26:271–282, 1991
    Google Scholar
  25. Kennedy SH, Qin H, Lin L, Tan EM: Basic fibroblast growth factor regulates type I collagen and collagenase gene expression in human smooth muscle cells. Am J Pathol 146:764–771, 1995
    Google Scholar
  26. Savage MP, Hart CE, Riley BB, Sasse J, Olwin BB, Fallon JF: Distribution of FGF-2 suggests it has a role in chick limb bud growth. Dev Dyn 198:159–170, 1993
    Google Scholar
  27. Rutland P, Pulleyn LJ, Reardon W, Baraitser M, Hayward R, Jones B, Malcolm S, Winter RM, Oldridge M, Slaney SF, Poole MD, Wilkie AO: Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes. Nature Genet 9:173–176, 1995
    Google Scholar
  28. Reidy MA: Neointimal proliferation: The role of basic FGF on vascular smooth muscle proliferation. Thromb Haemost 70:172–176, 1993
    Google Scholar
  29. Mazue G, Bertolero F, Jacob C, Sarminetos P, Ronrucci R: Preclinical and clinical studies with recombinant human basic fibroblast growth factor. Ann NY Acad Sci 638:329–340, 1991
    Google Scholar
  30. Davidson JM, Broadley KN: Manipulation of the wound-healing process with basic fibroblast growth factor. Ann NY Acad Sci 638:306–315, 1991
    Google Scholar
  31. Duensing S, Atzpodien J: Increased intracellular and plasma levels of basic fibroblast growth factor in B-cell chronic lymphocytic leukemia. Blood 85:1978–1980, 1995
    Google Scholar
  32. Nguyen M, Watanabe H, Budson AE, Richie JP, Hayes DF, Folkman J: Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Nat Cancer Inst 86:356–361, 1994
    Google Scholar
  33. Folkman J, Szabo S, Stovroff M, McNeil P, Li M, Shing Y: Duodenal ulcer: Discovery of a new mechanism and development of angiogenic therapy that accelerates healing. Ann Surg 214:414–427, 1991
    Google Scholar
  34. Proujansky R, Carpenter AB: Soluble interleukin-2 receptor as a marker of lymphocyte activation in childhood Crohn's disease. J Pediatr Gastroenterol Nutr 13:277–284, 1991
    Google Scholar
  35. Gilmour HM: Crohn's disease. In Gastrointestinal and Oesophageal Pathology. R Whitehead (ed). Edinburgh, Churchill Livingstone, 1989, pp 458–467
    Google Scholar
  36. Dvorak HF, Brown LF, Detmar M, Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1030–1039, 1995
    Google Scholar

Download references